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Introduction {#sec1}
============

Telomeres are complex nucleoprotein structures that protect chromosome ends from DNA damage responses (DDR). The most terminal DNA on a chromosome is typically G-rich 3′ single-stranded DNA (ssDNA), resembling a DNA double-strand break (DSB) in the process of repair by homologous recombination. In budding yeast, CST (Cdc13, Stn1, and Ten1), proteins are proposed to form a heterotrimeric telomeric ssDNA-binding complex, that helps cap telomeres and is analogous to the heterotrimeric RPA complex that binds nuclear ssDNA during the process of transcription, DNA replication, and repair ([@bib16; @bib47; @bib48]). Cdc13 binds telomeric ssDNA strongly via an oligonucleotide/oligosacccharide binding (OB) fold ([@bib31]). Stn1 and Ten1 also bind telomeric ssDNA but with lower affinity than Cdc13 and are thought to be recruited to DNA via Cdc13 ([@bib16; @bib45; @bib46]). So far, the budding yeast CST complex has not been purified, but recent evidence from the distant yeast *Candida glabrata* suggests that in this organism CST functions as a 2:4:2 or 2:6:2 complex ([@bib32]).

Orthologs of CST components have recently been identified in mammals, plants, and fission yeast. The human components of CST (CTC1, STN1 \[OBFC1\], and TEN1) can be purified as a trimeric complex ([@bib9; @bib19; @bib36; @bib49]). Mutations in CTC1 are associated with human diseases and have been associated with cellular telomere defects ([@bib10; @bib2]). Interestingly, CTC1 and STN1 were originally identified when copurified with human DNA polymerase alpha and named alpha accessory factor (AAF) ([@bib7]). The interaction of CST with DNA polymerase alpha is conserved because budding yeast Cdc13 and Stn1 also bind to DNA polymerase alpha components ([@bib44; @bib23]).

In budding yeast, where CST was first identified, there is evidence that CST subunits perform different functions. For example, Cdc13 helps recruit telomerase via interaction with the telomerase subunit Est1 ([@bib38; @bib44; @bib35]). In contrast, Stn1 interferes with telomerase activity because Stn1 and Est1 have overlapping binding sites on Cdc13, and Stn1 inhibits telomerase activity by competing with Est1 for Cdc13 binding ([@bib43; @bib8]). Another example is that Stn1, when overproduced, acts as a checkpoint inhibitor ([@bib18]). However, because Cdc13, Stn1, and Ten1 are each essential proteins in budding yeast, and there is clear homology to RPA, it is suggested that CST proteins function together to provide the essential function of capping the telomere ([@bib16]).

In yeast and human cells, nonsense mediated mRNA decay (NMD) proteins play important roles at telomeres. NMD degrades transcripts containing premature termination codons (PTCs) to reduce the risk that potentially harmful truncated proteins (or RNA) are made in cells ([@bib27]). It is estimated that about 10% of human diseases are associated with PTCs ([@bib5]). In human cells, the key NMD proteins UPF1, UPF2, and UPF3 bind to telomeres, and telomere loss occurs in UPF1 and UPF2-depleted cells ([@bib30; @bib3]). Consistent with the telomere effect in human cells, budding yeast *nmdΔ* mutants show a short telomere phenotype. Interestingly, in yeast *nmdΔ* mutants overexpression of Stn1 and Ten1 is largely responsible for the short telomere length phenotype ([@bib12]). This is presumably because Stn1/Ten1 inhibits telomerase activity by interfering with Est1-Cdc13 interaction.

We have previously reported that disabling NMD (*NAM7*, *NMD2*, and *UPF3*) or DDR genes such as *EXO1,* encoding a nuclease, or *RAD24*, encoding the checkpoint sliding clamp loader, suppresses temperature sensitivity of telomere-defective *cdc13-1* strains to similar extents ([@bib1]). Given the important roles played by CST, NMD, and DDR proteins at mammalian and yeast telomeres, we wanted to better understand the interplay between NMD and DDR at uncapped telomeres. Remarkably, we find that deleting *NMD2* with either *EXO1* or *RAD24* completely bypasses the requirement for Cdc13. However, the same genetic interventions do not bypass the need for either Stn1 or Ten1. These and other molecular experiments indicate that CST does not always function as an RPA-like trimeric protein in yeast. Instead, our data show that Stn1 and Ten1 are critical for cell viability in conditions when Cdc13 is not, and this suggests that Stn1 and Ten1 can cap telomeres, or perform other essential functions, in the absence Cdc13.

Results {#sec2}
=======

*cdc13-1* Can Be Strongly Suppressed by *nmd2Δ* with *exo1Δ* and/or *rad24Δ* {#sec2.1}
----------------------------------------------------------------------------

The Cdc13-1 protein becomes increasingly defective at capping the telomere as temperatures increase. At high temperatures, *cdc13-1* cells accumulate telomeric ssDNA, activate checkpoint pathways, and arrest before anaphase ([@bib17]). To begin to systematically define the proteins and pathways that are important for telomere function, *cdc13-1* was combined with the yeast genome knockout collection to identify suppressors and enhancers of the temperature-sensitive telomere defect ([@bib1]). We found that deletions of NMD genes (*nam7Δ*, *nmd2Δ*, and *upf3Δ*), which cause short telomere phenotypes, suppress the *cdc13-1* defect strongly. The effects of *nmdΔ* mutations were as strong as deletions affecting aspects of the DNA Damage Response (DDR), including deletions of DNA damage checkpoint genes (*ddc1Δ*, *rad9Δ*, *rad17Δ*, and *rad24Δ*) or *exo1Δ*, affecting a nuclease that attacks uncapped telomeres ([Figure 1](#fig1){ref-type="fig"}A). Interestingly, other deletions affecting the DDR or telomerase cause a short telomere phenotype but enhanced the *cdc13-1* defect; such proteins include the Ku complex (Yku70, Yku80), the MRX complex (Mre11, Rad50, Xrs2), or telomerase (Est1 and Est3 regulatory subunits). Therefore, *nmdΔ* mutations are somewhat unusual in that they result in short telomeres but suppress *cdc13-1*.

To better understand the role of NMD at telomeres, we investigated the overlap between NMD and the DDR. We generated all possible combinations of *nmd2Δ*, *exo1Δ*, and *rad24Δ* mutations in *cdc13-1* strains. We observed strong synergistic interactions between *nmd2Δ* and *exo1Δ* or *rad24Δ* mutations. Specifically, deleting *nmd2Δ* in combination with *exo1Δ* or *rad24Δ* in *cdc13-1* strains significantly increased strain fitness compared to each single gene deletion ([Figure 1](#fig1){ref-type="fig"}B). In contrast, *exo1Δ rad24Δ* double deletions only marginally improved growth compared to *exo1Δ* or *rad24Δ* single deletions. We conclude that NMD inhibits the growth of *cdc13-1* mutants by a mechanism that is distinct to the effects of Exo1 and Rad24, which are more similar in effect. The *nmd2Δ rad24Δ exo1Δ cdc13-1* strain was most fit, growing robustly at 36°C, demonstrating that Nmd2, Rad24, and Exo1 each perform different functions to inhibit growth of *cdc13-1* mutants. The synergistic genetic interactions between NMD and the DDR indicate that that NMD functions in parallel to the DDR proteins Exo1 and Rad24 to inhibit growth of *cdc13-1* mutants.

*nmd2Δ* Affects ssDNA Accumulation in *cdc13-1* Strains {#sec2.2}
-------------------------------------------------------

Exo1 and Rad24 inhibit growth of *cdc13-1* strains at least in part by generating single-stranded DNA (ssDNA) at uncapped telomeres ([@bib53]). To test the effect of Nmd2 on ssDNA, we measured ssDNA near telomeres in *nmd2Δ cdc13-1* and *nmd2Δ rad9Δ cdc13-1* strains. The checkpoint protein Rad9, like its mammalian ortholog 53BP1, inhibits ssDNA accumulation and was used to sensitize some strains to the accumulation of ssDNA ([@bib29; @bib6]). We used quantitative amplification of single-stranded DNA (QAOS) to measure ssDNA accumulation at the *DUG1* and *RET2* loci on the right arm of chromosome VI-R ([@bib26]) ([Figure 2](#fig2){ref-type="fig"}A). Deleting *NMD2* reduced the amount of ssDNA generated in *cdc13-1* or *cdc13-1 rad9Δ*-strains at loci 20 or 30 kb from uncapped telomeres ([Figures 2](#fig2){ref-type="fig"}B--2E). We further investigated the effect of deleting *NMD2* on telomeric ssDNA by using a fluorescent native in-gel assay to measure ssDNA in telomeric repeats in *nmd2Δ cdc13-1* strains, grown at a restrictive temperature. Consistent with the QAOS data, we observed reduced ssDNA accumulation in the telomeric repeats of *nmd2Δ cdc13-1* strains after 4 hr at 36°C ([Figure 2](#fig2){ref-type="fig"}F). To obtain independent evidence that *NMD2* affects ssDNA, we measured the effect of *nmd2Δ* on cell viability of *cdc13-1* and *cdc13-1 rad9Δ* strains subjected to restrictive and permissive temperature cycles in an "up-down" assay ([Figures 2](#fig2){ref-type="fig"}G and [S1](#app2){ref-type="sec"}A). Deleting *NMD2* in a *cdc13-1* or *cdc13-1 rad9Δ* background increased cell viability assessed by spot tests after growth at 36°C, similar to the effect of deleting *EXO1* in the same backgrounds ([Figure 2](#fig2){ref-type="fig"}G). This spot test result was confirmed by determining cell viability after incubation at restrictive temperature: *nmd2Δ cdc13-1 rad9Δ* cultures contained nearly 8% viable cells compared to around 1% of *cdc13-1 rad9Δ* cultures at the 240 min time point ([Figure S1](#app2){ref-type="sec"}B). We conclude that Nmd2, like Rad24 and Exo1, affects ssDNA levels in *cdc13-1* mutants.

*nmd2Δ* rescued loss of viability caused by rapid accumulation of ssDNA in *cdc13-1* mutants, similar to the previously reported effects of *exo1Δ* and *rad24Δ* mutations ([@bib53]). It is known that disabling NMD pathways increases the levels of many telomere related proteins and RNAs, including the Ku complex, telomerase, Telomeric Repeat Containing RNA (TERRA), and the Cdc13 partner proteins Stn1 and Ten1 ([@bib25; @bib3; @bib12; @bib1]). It is likely therefore that disabling the NMD pathway increases the levels of one or more of these telomere related proteins or RNAs and thereby reduces resection of telomeric ssDNA. Alternatively, NMD may regulate an unidentified nuclease that attacks telomeric DNA, play a direct role in resection, or affect the stability of ssDNA generated in *cdc13-1* strains.

The Requirement for *CDC13* Can Be Bypassed {#sec2.3}
-------------------------------------------

The robust growth of *nmd2Δ rad24Δ exo1Δ cdc13-1* mutants at 36°C suggested that cells deficient in NMD and DDR might be able to divide in the absence of any Cdc13 function. To test this, we deleted *CDC13* in a diploid strain that carried heterozygous deletions of *UPF1*, *EXO1*, and *RAD24*. We sporulated the diploid, dissected tetrads, and germinated the spores. Consistent with our hypothesis, 100% of *nmd2Δ rad24Δ cdc13Δ, nmd2Δ exo1Δ cdc13Δ*, and *nmd2Δ rad24Δ exo1Δ cdc13Δ* spores formed visible colonies, whereas all other *cdc13Δ* genotypes did not ([Figures 3](#fig3){ref-type="fig"}A and [S2](#app2){ref-type="sec"}A). Inviable *cdc13Δ* strains formed microcolonies, and the sizes of microcolonies were increased by *nmd2Δ*, *exo1Δ*, or *rad24Δ* mutations ([Figures 3](#fig3){ref-type="fig"}B and [S2](#app2){ref-type="sec"}B), just as the deletions improved fitness of *cdc13-1* cells at semipermissive temperatures ([Figure 1](#fig1){ref-type="fig"}B). Therefore, combining disruptions affecting NMD with those affecting *EXO1* and *RAD24* can permit cell division in the absence of Cdc13.

Because some *cdc13Δ* genotypes form visible colonies, whereas other *cdc13Δ* genotypes form only microscopic colonies, we wondered whether cells in large *cdc13Δ* colonies might eventually stop dividing. To examine fitness over time, we subcultured viable *cdc13Δ* strains for many passages and measured fitness by spot test. Fitness of the *cdc13Δ* strains increased rather than decreased with time ([Figure 3](#fig3){ref-type="fig"}C), similar to telomerase-deficient strains (*tlc1Δ*), which escape senescence and maintain telomere length by mechanisms independent of telomerase ([@bib33; @bib51]). Consistent with this similarity, when we examined telomere structures of *cdc13Δ* strains they were altered by passage 9 and showed rearrangements like telomerase-deficient survivors ([Figure 3](#fig3){ref-type="fig"}D). We conclude that *cdc13Δ* cells are viable indefinitely and rearrange their telomere structures like telomerase-deficient cells.

Given that *cdc13Δ* cells rearranged telomeres like telomerase-deficient *tlc1Δ* cells, we wondered if they needed functional telomerase in order to divide, as *cdc13Δ pif1Δ exo1Δ* have been demonstrated to depend on telomerase for survival ([@bib13]). We germinated spores derived after introducing a *tlc1Δ* disruption into a diploid strain containing heterozygous deletions of *CDC13*, *NMD2*, *RAD24*, or *EXO1*. We found viable *cdc13Δ tlc1Δ* strains when *nmd2Δ* and *exo1Δ*, *rad24Δ*, or *exo1Δ rad24Δ* were present ([Figure S3](#app2){ref-type="sec"}A). Furthermore such strains could be cultured for many passages, showed increased fitness over time and altered telomere structure like telomerase-deficient survivors ([Figures S3](#app2){ref-type="sec"}B and S3C). We conclude that *nmd2Δ cdc13Δ* strains use telomerase-independent mechanisms to maintain telomere length.

The Requirement for *STN1 and TEN1* Cannot Be Bypassed {#sec2.4}
------------------------------------------------------

To test whether yeast cells survive without the Stn1 or Ten1, the other components of the CST complex, we introduced *stn1Δ* or *ten1Δ* disruptions into the diploid strain containing heterozygous deletions of *NMD2*, *RAD24*, or *EXO1*. In contrast to what was found with *cdc13Δ*, we could not identify any visible *stn1Δ* or *ten1Δ* colonies ([Figures 4](#fig4){ref-type="fig"}, [S4](#app2){ref-type="sec"}A, and S4B). Interestingly, germinated *stn1Δ* and *ten1Δ* spores often formed microcolonies like some of the *cdc13Δ* genotypes ([Figures 4](#fig4){ref-type="fig"} and [3](#fig3){ref-type="fig"}B). Therefore, *stn1Δ* and *ten1Δ* cells sometimes undergo a limited number of cell divisions but cannot divide indefinitely, irrespective of the status of *NMD2*, *RAD24*, or *EXO1*. Similarly, *cdc13Δ*, *nmd2Δ cdc13Δ*, *exo1*Δ *cdc13Δ*, *rad24Δ cdc13Δ*, and *exo1Δ rad24Δ cdc13Δ* cells sometimes undergo a few cell divisions before stopping division ([Figure 3](#fig3){ref-type="fig"}B). We note that others have reported that *stn1Δ rad24Δ* microcolonies are smaller than *cdc13Δ rad24Δ* microcolonies, which is consistent with our data ([@bib39]). In summary, all these microcolony patterns suggest that *stn1Δ* and *ten1Δ* strains have similar but more severe growth defects than *cdc13Δ* strains.

One explanation for the fitness differences between *cdc13Δ* and *stn1Δ* or *ten1Δ* strains was that fitness differences were not due to CST defects per se but instead because important genes adjacent to *STN1* and *TEN1* were affected in deletion strains ([@bib4]). However, this is not the case because the essential functions missing in *stn1Δ* and *ten1Δ* strains could be rescued by expressing the missing *STN1* or *TEN1* genes on plasmids ([Figure S4](#app2){ref-type="sec"}C). Furthermore, the strains relying on plasmid-borne *STN1* or *TEN1* could not lose such plasmids ([Figure S4](#app2){ref-type="sec"}D). Given that several defined genetic backgrounds allow growth of *cdc13Δ* but not of *stn1Δ* or *ten1Δ* strains, this strongly implies that Stn1 and Ten1 are more critical for cell viability than Cdc13.

Our experiments show that budding yeast cells defective in NMD and Exo1 or Rad24 can grow indefinitely without Cdc13 and telomerase, but that in such cells telomere function is compromised. However, cells with otherwise identical genetic backgrounds cannot grow in the absence of Stn1 or Ten1. The simplest explanation for these observations is that Stn1 and Ten1 play additional roles to Cdc13 in maintaining budding yeast cell viability. Consistent with this data, other experiments have shown that truncated and overexpressed versions of Stn1/Ten1 can bypass the need for Cdc13 ([@bib40; @bib41; @bib18]).

It has been shown that the *nmd2Δ* telomere phenotype is due, at least in part, to elevated Stn1 levels. Specifically, overexpression of *STN1*, or simultaneous overexpression of *STN1* and *TEN1*, leads to short telomeres of a similar length to *nmd2Δ* mutants ([@bib12]). Therefore, we wondered whether growth of *cdc13Δ* cells depended on Stn1 and/or Ten1 overproduction. To test this hypothesis, we examined a different genetic background that was not expected to affect Stn1 levels.

Pif1 is a helicase that is active at telomeres and deletion of *PIF1* and *EXO1* also permits deletion of *CDC13* ([@bib13]). We repeated previous experiments and were able to generate viable strains from germinated *cdc13Δ pif1Δ exo1Δ* spores. However, we were unable to generate equivalent *stn1Δ* or *ten1Δ* strains ([Figures 5](#fig5){ref-type="fig"}A--5C and [S5](#app2){ref-type="sec"}), reproducing what was found in other genetic backgrounds ([Figure 4](#fig4){ref-type="fig"}). These results strongly suggested that overexpression of Stn1 was not necessary to bypass Cdc13 function. However, it remained possible that *pif1Δ* or *exo1Δ* mutations caused increased Stn1 or Ten1 levels. Therefore, we measured Stn1 and Ten1 RNA expression levels in *pif1Δ*, *exo1Δ*, and *pif1Δ exo1Δ* strains, using quantitative RT-PCR (qRT-PCR). In these strains, levels of *STN1* and *TEN1* RNA were not significantly different from wild-type ([Figures 5](#fig5){ref-type="fig"}D and 5E), whereas, as expected, levels of *STN1* and *TEN1* RNAs were increased by an *nmd2Δ* mutation. Finally, it was possible that Stn1 or Ten1 might be transcriptionally induced by the response to telomere uncapping in *cdc13Δ* cells. However, this is not the case because there is no significant increase in *STN1* and *TEN1* RNA levels in *cdc13-1* strains grown at high temperatures ([@bib22]). We conclude that bypass of the requirement for Cdc13 does not depend on *nmd2Δ*-dependent overexpression of *STN1* and/or *TEN1*. Instead, our data suggest that at normal levels of expression Stn1 and Ten1 can, in some circumstances, function without Cdc13 to maintain viability of yeast cells.

Stn1, Ten1, and Cdc13 Can Bind Telomeric DNA at Different Ratios {#sec2.5}
----------------------------------------------------------------

Our experiments show that Stn1 and Ten1 contribute to yeast cell viability in conditions when Cdc13 is not required. To see if the essential function provided by Stn1 or Ten1 was at telomeres, we asked whether disabling the NMD pathway affected the ratio of CST components at telomeres. To investigate this, we used a chromatin immunoprecipitation (ChIP) assay to measure binding of myc-tagged *STN1*, *TEN1*, and *CDC13* to telomeric DNA, in wild-type or *nmd2Δ* backgrounds. We observed about a 10-fold increase in binding of Stn1 and a 5-fold increase for Ten1 to telomeres in *nmd2Δ* mutants but only a 2-fold increase in the levels of Cdc13 ([Figures 6](#fig6){ref-type="fig"}A--6C). We conclude that Cdc13, Stn1, and Ten1, the components of the CST complex, can bind telomeres at different ratios.

Given that we were able to delete Cdc13, but could not delete Stn1 or Ten1, the other two components of the CST complex, this suggests that Stn1 or Ten1 might help cap the telomere in the complete absence of Cdc13. We tested this hypothesis using a ChIP assay. We found that Stn1-Myc was indeed bound to telomeric DNA in a Cdc13-independent manner in an *nmd2Δ exo1Δ rad24Δ cdc13Δ* strain ([Figure 6](#fig6){ref-type="fig"}D). The level of Stn1 binding to telomeres was lower in the *cdc13Δ* strain compared to the *CDC13*^*+*^ strain; this could be due to the *cdc13Δ* cells having dramatically rearranged telomeres. We did not find evidence of Ten1 binding to telomeres in the absence of Cdc13 ([Figure 6](#fig6){ref-type="fig"}E). However, Ten1 enrichment at telomeres was also relatively weak in the *nmd2Δ exo1Δ rad24Δ* strain, and it may be that any binding is below our detection limit. RPA is another ssDNA binding protein, binds at telomeres, and is therefore likely to compete with Cdc13 as a telomeric ssDNA binding protein. Consistent with this hypothesis, we measured more RPA bound to telomeres in the absence of Cdc13 ([Figure 6](#fig6){ref-type="fig"}F). This suggests that in the absence of Cdc13, RPA can bind telomeric DNA and that RPA cooperates with Stn1, Ten1, and other proteins to cap the telomere. We conclude that Stn1 can bind telomeres in the absence of Cdc13.

Discussion {#sec3}
==========

We have shown that NMD acts in a parallel pathway to the Exo1 and Rad24 DDR proteins to inhibit growth of yeast cells with defective telomeres. Furthermore, we show that NMD, like Exo1 and Rad24, affects the level of telomeric ssDNA. Remarkably, we find that the requirement for *CDC13* can be robustly bypassed in 100% of cells with *nmd2Δ* and *exo1Δ* or *rad24Δ* mutations. Viable *cdc13Δ* strains can be cultured for many passages, and the telomeres in such cells resemble those of telomerase-deficient survivors and still bind Stn1. In contrast, none of the four genetic backgrounds that allow robust bypass of *cdc13Δ* allowed bypass of *stn1Δ* or *ten1Δ*.

Cdc13, along with Stn1 and Ten1, has been proposed to form an essential heterotrimeric telomeric ssDNA binding complex analogous to RPA, the ssDNA binding complex ([@bib16]). The CST/RPA model is attractive for many reasons, perhaps most notably because all three CST subunits are, like the RPA subunits, essential for yeast cell viability, and all three contribute to telomere protection. However, we have identified several defined genetic backgrounds that permit deletion of *CDC13*, but none of these permit deletion of *STN1* or *TEN1*. The simplest explanation for these data is that Stn1 and Ten1 play Cdc13-independent roles at the telomere, or elsewhere. We show that *STN1* and *TEN1* binding to telomeric DNA increases more than Cdc13 in *nmd2Δ* strains, which suggests that Stn1 and Ten1 can bind telomeric DNA without Cdc13. Indeed, we also show that Stn1 binds to telomeric DNA in the absence of Cdc13. Consistent with our data, others have shown that C-terminal truncations of Stn1, which disrupt the Stn1-Cdc13 interaction, are sufficient to support cell viability and telomere function ([@bib41]). Interestingly, Stn1 overproduction inactivates the S phase checkpoint in budding yeast, and, although the biochemical mechanism explaining this interaction is not known, it is tempting to speculate that some aspect of this checkpoint inhibition function is critical for Stn1 function ([@bib18]). We conclude that budding yeast Cdc13---the largest component of the CST complex---contributes to a subset of the essential functions performed by its smaller partners, Stn1 and Ten1.

Ten1 was the last of the budding yeast CST components to be identified, in 2001 ([@bib21]). It was only much more recently that orthologs of CST components were identified in higher eukaryotes ([@bib19]). Our data from budding yeast, showing that *STN1* and *TEN1* are critical for cell viability in conditions when *CDC13* is not, are consistent with data from other organisms, suggesting that this pattern might be universally the case in eukaryotes. For example, so far, no ortholog of Cdc13 has yet been reported in fission yeast but orthologs of both Stn1 and Ten1 have been identified ([@bib28]). Also, mutations in human *CTC1*, the ortholog of *CDC13*, are found in a number of diseases associated with telomere defects (Coats plus, *dyskeratosis congenita* and CRMCC); however, no equivalent mutations in *STN1* or *TEN1* have yet been identified in the same cohorts of patients ([@bib2; @bib42; @bib50]). Perhaps mutations in Stn1 or Ten1 in humans cause stronger phenotypes that are not tolerated.

We have previously shown that some *cdc13Δ* strains can also be deleted of *STN1* ([@bib52]). *stn1Δ* strains grew less well than the parental (*cdc13Δ*) strains, and we were unable to identify any *ten1Δ* strains. These data, and those we report here, show that a functional telomere is very flexible in terms of the proteins it contains. The possibility remains that conditions will be identified that permit bypass of Stn1 and or Ten1 but not of Cdc13. A better understanding of the functions of Cdc13, Stn1, and Ten1 at telomeres will be important to see if this is likely. As it stands, our data suggest there is a functional hierarchy of CST subunit function in budding yeast with Ten1 more critical than Stn1, which is more critical than Cdc13.

If Stn1 and Ten1 function at eukaryotic telomeres in the absence of Cdc13, then how do they do so? Because Stn1 and Ten1 have low affinity for telomeric DNA (in comparison with Cdc13), one simple explanation is that Stn1 and Ten1 bind and cap the telomere via interactions with any of the numerous other telomere binding proteins or RNAs. The idea that Stn1 interacts with proteins other than Cdc13 to perform essential functions is consistent with data showing that the Ten1 interaction domain of Stn1 is much more critical for cell viability than the Cdc13 interaction domain ([@bib41]). Stn1/Ten1 might interact with one or more than one of numerous other proteins found at budding yeast telomeres, and elsewhere, including Rap1, Rif1, Rif2, Ku, MRX, Tel1, Telomerase, Sir proteins, RPA, and DNA polymerase alpha. We tested a model in which subunits of RPA formed heterotrimers with CST subunits, but we could obtain no strong evidence for such a model (data not shown). However, we did observe increased binding of RPA to telomeres in the absence of Cdc13. Both budding yeast and mammalian CST components interact with Pol α primase and in yeast this interaction has been shown to promote telomere capping ([@bib23; @bib18; @bib44; @bib2]). In mammalian cells, CST components facilitate the replication of telomeric lagging-strand DNA ([@bib48; @bib37]). It will be interesting to determine how telomeres are capped and replication is completed in the absence of Cdc13.

Finally, given that CST and NMD play important roles in telomeres in yeast and humans, the genetic interactions we report in yeast may identify useful avenues to pursue for developing future treatments for the human diseases in which *CTC1* is affected ([@bib24]). Premature termination codons are responsible for around 10% of inherited human diseases and pharmaceuticals targeting NMD have been identified. If we extrapolate from the yeast experiments to human cells, it is conceivable that reducing NMD function pharmaceutically might compensate for loss of CTC1 function in patients.

Experimental Procedures {#sec4}
=======================

Yeast Strains {#sec4.1}
-------------

All strains are in the W303 background and are *RAD5*^+^ ([Supplemental Experimental Procedures](#app2){ref-type="sec"}, list 1). Gene disruptions of *CDC13*, *STN1*, and *TEN1* were created by inserting a hygromycin cassette into a diploid using one step PCR, primers indicated in [Supplemental Experimental Procedures](#app2){ref-type="sec"} (list 2) and a pAG32 plasmid harboring HPHMX4 ([@bib20]) ([Supplemental Experimental Procedures](#app2){ref-type="sec"}, list 3). Gene disruptions were confirmed by PCR. *STN1* and *TEN1* rescue plasmids were created by PCR-based gap repair of plasmid pDL1466 (see [Supplemental Experimental Procedures](#app2){ref-type="sec"}, list 3, for plasmid details).

Yeast Growth Assays {#sec4.2}
-------------------

Single colonies were inoculated into 2 ml of YEPD+adenine and grown in tubes at 23°C overnight until saturation. Six-fold serial dilution series of the cultures were spotted onto plates using a 48-prong replica-plating device. Plates were incubated for 2--3 days at temperatures indicated before being photographed. For cycling temperature assays plates were incubated at 23°C for 4 hr then 36°C for 4 hr, and this was repeated three times before colonies were allowed to form at 23°C. For passage experiments, several colonies were pooled with a toothpick and restruck onto YEPD plates.

ChIP {#sec4.3}
----

Chromatin immunoprecipitation was performed essentially as previously described ([@bib15]); cells were additionally crosslinked with 2 mM EGS. Mouse anti-myc 9E10 (ab32, Abcam) or anti-*Saccharomyces cerevisiae* RPA (AS07 214, Agrisera) or rabbit anti-goat immunoglobulin (Ig) G (ab97096, Abcam) antibodies were used for immunoprecipitations. Immunoprecipitated DNA was isolated using 10% Chelex (Bio-Rad) and quantified by qPCR using the SYBR Green pPCR SuperMIX-UDG w/ROX kit (Invitrogen, 11744500). Primers used for PCR are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}, list 2.

Synchronous Cultures and QAOS {#sec4.4}
-----------------------------

Synchronous culture experiments and viability assay were carried out in strains containing *bar1Δ cdc15-2* mutations and were performed as described ([@bib54]). Quantitative amplification of ssDNA was carried out as described ([@bib26]).

In-Gel Assay {#sec4.5}
------------

In-gel assays were performed as previously described ([@bib14]). The Cy5-labeled oligonucleotide (M2188) was detected on a GE Healthcare Typhoon Trio imager. The agarose gel was poststained using SYBR Safe, and total DNA was detected using a FUJI LAS-4000 imager. ssDNA was quantified using ImageJ and normalized relative to the loading control. The final fold change is relative to the 0 hr time point of each strain.

Microcolonies {#sec4.6}
-------------

After germination for 5 days at 23°C, colonies were photographed using a 20× objective on a Microtec microscope. An image was taken of each microcolony, and images are reproduced at the same scale for direct comparison.

Analysis of Telomere Structure {#sec4.7}
------------------------------

Southern blot analysis was performed essentially as previously described ([@bib34]). Genomic DNA was cut with XhoI (New England Biolabs), run overnight on a 0.8% agarose gel, and transferred to a positively charged nylon membrane. The membrane was hybridized with a 1 kbp Y′ and TG probe, obtained by digesting pDL987 with XhoI and BamHI. The probe was labeled, and the blot was hybridized and immunologically detected using the DIG-High Prime Labeling and Detection Kit (Roche, 11585614910). The probe was visualized using a FUJI LAS-4000 imager.

Quantitative RT-PCR {#sec4.8}
-------------------

RNA isolation was performed essentially as described ([@bib11]). RNA was further purified using the RNEasy Mini Kit (QIAGEN, 74104) and by DNase I digestion (Invitrogen, 18068-015). Quantitative RT-PCR was carried out using the Superscript III Platinum SYBR Green One-Step qRT-PCR kit (Invitrogen, 11736-059). RNA samples were normalized relative to the *BUD6* loading control.
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====================
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![Deletion Mutations that Suppress or Enhance *cdc13-1*\
(A) *cdc13-1* or *CDC13* strains were combined with the yeast knockout collection and fitness (maximum doubling rate × maximum doubling potential) determined at 27°C ([@bib1]). Each spot corresponds to the position of a single gene deletion. *cdc13-1* suppressors (red) or enhancers (green) are indicated, as are deletions known to affect telomere length (blue) or the DNA damage response (purple).\
(B) Saturated cultures, grown at 23°C, were serially diluted in water and spotted onto YEPD plates. Strains were grown at the temperatures indicated for 2 days before being photographed.](gr1){#fig1}

![Nmd2 Affects ssDNA Generation at Uncapped Telomeres\
(A) Schematic representation of chromosome arm VI-R.\
(B--E) Quantitative amplification of single-stranded DNA (QAOS) isolated from synchronous cultures of cells containing *bar1Δ*, *cdc13-1*, *cdc15-2*, and other mutations indicated. Error bars show 95% confidence interval values.\
(F) Cells dividing exponentially at 23°C were incubated at 36°C and ssDNA in the telomeric repeats was measured. SYBR Safe was used as a loading control. ssDNA was quantified using ImageJ and normalized relative to the loading control. The final fold change is relative to the 0 hr time point of each strain.\
(G) Yeast strains indicated were grown to saturation at 23°C before being spotted on two plates. One plate was incubated at 23°C for 3 days, the other plate was incubated for three 4 hr cycles at 36°C, separated by 4 hr at 23°C, before colonies were allowed to form at 23°C.\
See also [Figure S1](#app2){ref-type="sec"}.](gr2){#fig2}

![Bypass of *cdc13Δ*\
(A) *NMD2/nmd2Δ EXO1/exo1Δ RAD24/rad24Δ CDC13/cdc13Δ* diploids were sporulated. Tetrads were dissected onto YEPD plates, and spores were allowed to form colonies for 5 days at 23°C before being photographed.\
(B) Following germination of spores in (A), microcolonies were photographed using a 20× objective on a Microtec microscope and reproduced at the same scale. A representative subset of microcolonies is shown.\
(C) Strains of the genotypes indicated were repeatedly passaged by toothpick every 4 days at 23°C. At the indicated times, 2 ml liquid cultures were grown overnight, serially diluted, spotted onto YEPD plates, and incubated for 2 days before being photographed.\
(D) Genomic DNA was isolated from the yeast strains indicated, and telomere structures were analyzed by Southern blotting using a Y′ and TG probe. SYBR Safe was used as a loading control.\
See also [Figures S2](#app2){ref-type="sec"} and [S3](#app2){ref-type="sec"}.](gr3){#fig3}

![*stn1Δ* and *ten1Δ* Mutants Form Microcolonies\
(A and B) *NMD2/nmd2Δ EXO1/exo1Δ RAD24/rad24Δ STN1/stn1Δ* and *NMD2/nmd2Δ EXO1/exo1Δ RAD24/rad24Δ TEN1/ten1Δ* diploids were sporulated. Tetrads were dissected onto YEPD plates, and spores were allowed to form colonies for 5 days at 23°C before being photographed (see also [Figure S4](#app2){ref-type="sec"}). Following germination of spores, microcolonies were photographed using a 20× objective on a Microtec microscope and reproduced at the same scale.\
See also [Figure S4](#app2){ref-type="sec"}. We are uncertain about the genotypes of individual microcolonies as we cannot establish which gene deletions were inherited by each spore (in contrast to [Figure 3](#fig3){ref-type="fig"}B).](gr4){#fig4}

![Bypass of Cdc13 in a *pif1Δ exo1Δ* Strain Does Not Depend on Overexpression of Stn1 and Ten1\
(A--C) *PIF1/pif1Δ EXO1/exo1Δ CDC13/cdc13Δ*, *PIF1/pif1Δ EXO1/exo1Δ STN1/stn1Δ*, and *PIF1/pif1Δ EXO1/exo1Δ TEN1/ten1Δ* diploids were sporulated. Tetrads were dissected onto YEPD plates, and spores were allowed to form colonies for 5 days at 23°C before being photographed. See also [Figure S5](#app2){ref-type="sec"}.\
(D and E) qRT-PCR analysis of Stn1 and Ten1 RNA expression levels in the strains indicated. A single wild-type (WT) strain was given the value of 1, and the error bar indicates the value of the other wild-type strain. All other genotypes are expressed relative to the single wild-type strain, the mean of two independent strains is shown, and error bars indicate the individual value of each strain.\
See also [Figure S5](#app2){ref-type="sec"}.](gr5){#fig5}

![Altered Stoichiometry of CST Components at Telomeres\
(A--E) ChIP analysis of Cdc13-13Myc, Stn1-13Myc, and Ten1-13Myc binding to the VI-R telomere and the internal locus *PAC2* on chromosome V. Cultures of each genotype were grown at 23°C, and cells were harvested in exponential phase. Duplicate samples were immunoprecipitated with a Myc antibody (IP) or a nonspecific IgG control (BG). ChIP samples were measured in triplicate by qPCR, and group means are shown with error bars indicating SD.\
(F) ChIP analysis of RPA binding to the VI-R telomere and the internal locus *PAC2* on chromosome V. ChIP was conducted as in (A)--(E) using an anti-*S. cerevisiae* RPA antibody (IP) or a nonspecific IgG control (BG). ChIP samples were measured in triplicate by qPCR, and group means are shown with error bars indicating SD.](gr6){#fig6}
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